Garmin smartwatches reach new heights with Polaris Dawn space mission
Crew members will wear Garmin fēnix 7 adventure watches to help scientists understand how space travel affects the human body
Olathe, Kan./February 7, 2023 — Garmin smartwatches will play an important role in an upcoming Polaris Dawn human spaceflight, with highly accurate health data gleaned from fēnix® 7 adventure watches providing 24/7 insights into the impact of space travel on the human body. During the up to five-day mission launched from the SpaceX Falcon 9 rocket at NASA’s Kennedy Space Center in Florida, researchers will continuously monitor and collect crew members’ biometrics such as heart rate, pulse oximetry, and sleep patterns—all on a single battery charge.
“Garmin is honored to be a part of this exciting research effort that will advance the understanding of how the human body adapts to the rigors of space flight,” said Dan Bartel, Garmin vice president of global sales. “The exceptional battery life of our smartwatches will allow researchers the opportunity to continuously monitor all four crew members while awake and at rest over the five-day mission—with no down time needed to recharge the battery.”
The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine is supporting health and biomedical research aboard the historic Polaris Dawn mission, which will attempt to reach the highest Earth orbit ever flown with humans and complete the first-ever commercial spacewalk. The Polaris Dawn crew and the TRISH team chose Garmin smartwatches for the mission because of their long battery life, rugged durability and extensive suite of all-day health monitoring features.
“The trove of biometric data provided by Garmin fēnix smartwatches will allow us to better understand how the body adjusts to being in space,” said Jimmy Wu, TRISH senior biomedical engineer. “Once collected, this physiological data will be added to TRISH’s EXPAND database, aiding current and future research to study and understand human health and performance for all future human space exploration missions.”
SpaceX’s Falcon 9 rocket will launch the Polaris Dawn crew aboard a Dragon spacecraft from NASA’s Kennedy Space Center in Cape Canaveral, FL later in 2023. Garmin Health provides custom enterprise business solutions that leverage Garmin’s extensive wearable portfolio and high-quality sensor data for applications in the corporate wellness, population health, and patient monitoring markets. The Garmin Health API allows third parties to ask customers to share their data in accordance with their specific privacy policies. As part of a global company that designs, manufactures and ships products worldwide, Garmin Health supports its customers’ commerce and logistics needs, allowing enterprises to scale with a single, trusted provider. For more information, email our press team, connect with us on LinkedIn, or visit us online at garmin.com/health.
About Garmin International, Inc.
Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin and fēnix are registered trademarks of Garmin Ltd. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.
About Polaris Dawn
Polaris Dawn is the first of the Polaris Program’s three human spaceflight missions. SpaceX is targeting no earlier than March 2023 for Falcon 9’s launch of Dragon and the Polaris Dawn crew from Launch Complex 39A at NASA’s Kennedy Space Center in Florida. Polaris Dawn endeavors to reach the highest Earth orbit ever flown, attempt the first-ever commercial spacewalk, conduct extensive research to further our understanding of human health on Earth and during future long-duration spaceflights, and test Starlink’s laser-based communications in space. For more information, visit polarisprogram.com.
About the Translational Research Institute for Space Health
The Translational Research Institute for Space Health (TRISH) is a lean, virtual institute empowered by the NASA Human Research Program to solve the challenges of human deep space exploration. TRISH relentlessly pursues and funds novel research to deliver high-impact scientific and technological solutions that advance space health and help humans thrive wherever they explore, in space or on Earth. Led by Baylor College of Medicine’s Center for Space Medicine, the TRISH consortium leverages partnerships with Caltech and MIT. Learn more at bcm.edu/spacehealth.
Notice on Forward-Looking Statements
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management’s current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 25, 2021, filed by Garmin with the Securities and Exchange Commission (Commission file number 0001-411180). A copy of such Form 10-K is available at http://www.garmin.com/aboutGarmin/invRelations/finReports.html. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Contact
Krista Klaus
Garmin International, Inc.
Phone | 913-397-8200
E-Mail | [email protected]
Public Company Information
NYSE: GRMN
